{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T19:52:18Z","timestamp":1656532338444},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This study is funded by Beijing Municipal Science & Technology Commission","award":["Z191100006619014","Z191100006619014","Z191100006619014","Z191100006619014","Z191100006619014","Z191100006619014","Z191100006619014","Z191100006619014"],"award-info":[{"award-number":["Z191100006619014","Z191100006619014","Z191100006619014","Z191100006619014","Z191100006619014","Z191100006619014","Z191100006619014","Z191100006619014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To study the protein and mRNA expressions of regulator of G-protein signaling 5 (RGS5) in the pathogenesis of hyperparathyroidism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression of RGS5 protein in 20 primary hyperparathyroidism (PHPT), 31 secondary hyperparathyroidism (SHPT), and 20 control cases were studied by immunohistochemistry (IHC). The expression of RGS5 mRNA in 15 PHPT, 102 SHPT, and 7 normal parathyroid tissue were measured by quantitative real-time PCR (qRT-PCR) method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The expressions of RGS5 in PHPT tissues were significantly higher than that in SHPT and normal parathyroid tissues (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). While the differences in RGS5 protein expressions between SHPT and respective control samples were not statistically significant (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). Likewise, the <jats:italic>RGS5<\/jats:italic> mRNA expression in PHPT was significantly higher than that in SHPT (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) and normal parathyroid (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) samples. In a similar line, the differences in <jats:italic>RGS5<\/jats:italic> gene expressions between SHPT and control tissues were not statistically significant (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The characteristic RGS5 protein and mRNA levels in hyperparathyroidism might be helpful in discovering the pathomechanism of hyperparathyroidism and novel therapeutic targets as well.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-022-01066-8","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T20:48:19Z","timestamp":1654807699000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implications of regulator of G-protein signaling 5 expression in the pathogenesis of primary and secondary hyperparathyroidism"],"prefix":"10.1186","volume":"22","author":[{"given":"Xin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiping","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"issue":"1","key":"1066_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2215\/CJN.12941213","volume":"10","author":"F Tentori","year":"2015","unstructured":"Tentori F, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol. 2015;10(1):98\u2013109.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"1066_CR2","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1080\/0886022X.2016.1184924","volume":"38","author":"L Chen","year":"2016","unstructured":"Chen L, et al. Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis. Ren Fail. 2016;38(7):1050\u20138.","journal-title":"Ren Fail"},{"issue":"8","key":"1066_CR3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00423-018-1726-6","volume":"403","author":"WY van der Plas","year":"2018","unstructured":"van der Plas WY, et al. Safety and efficacy of subtotal or total parathyroidectomy for patients with secondary or tertiary hyperparathyroidism in four academic centers in the Netherlands. Langenbecks Arch Surg. 2018;403(8):999\u20131005.","journal-title":"Langenbecks Arch Surg"},{"issue":"20","key":"1066_CR4","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/j.ehj.2004.07.010","volume":"25","author":"P Andersson","year":"2004","unstructured":"Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease\u2013a review. Eur Heart J. 2004;25(20):1776\u201387.","journal-title":"Eur Heart J"},{"issue":"3","key":"1066_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s12022-018-9524-9","volume":"29","author":"AG Sengul","year":"2018","unstructured":"Sengul AG, et al. Clinical Impact of p27(Kip1) and CaSR Expression on Primary Hyperparathyroidism. Endocr Pathol. 2018;29(3):250\u20138.","journal-title":"Endocr Pathol"},{"issue":"5","key":"1066_CR6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1210\/me.2010-0277","volume":"25","author":"J Koh","year":"2011","unstructured":"Koh J, et al. Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor. Mol Endocrinol. 2011;25(5):867\u201376.","journal-title":"Mol Endocrinol"},{"issue":"3","key":"1066_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1124\/pr.54.3.527","volume":"54","author":"S Hollinger","year":"2002","unstructured":"Hollinger S, Hepler JR. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev. 2002;54(3):527\u201359.","journal-title":"Pharmacol Rev"},{"issue":"7193","key":"1066_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nature06868","volume":"453","author":"J Hamzah","year":"2008","unstructured":"Hamzah J, et al. Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature. 2008;453(7193):410\u20134.","journal-title":"Nature"},{"issue":"1","key":"1066_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000343403","volume":"37","author":"J Latus","year":"2013","unstructured":"Latus J, et al. Analysis of alpha-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism. Kidney Blood Press Res. 2013;37(1):84\u201394.","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"1066_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12020-013-9881-6","volume":"44","author":"J Latus","year":"2013","unstructured":"Latus J, et al. Involvement of alpha-klotho, fibroblast growth factor-, vitamin-D- and calcium-sensing receptor in 53 patients with primary hyperparathyroidism. Endocrine. 2013;44(1):255\u201363.","journal-title":"Endocrine"},{"issue":"4","key":"1066_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/ng1295-389","volume":"11","author":"C Ho","year":"1995","unstructured":"Ho C, et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet. 1995;11(4):389\u201394.","journal-title":"Nat Genet"},{"issue":"25","key":"1066_CR12","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","volume":"365","author":"C Marcocci","year":"2011","unstructured":"Marcocci C, Cetani F. Clinical practice. Primary hyperparathyroidism. N Engl J Med. 2011;365(25):2389\u201397.","journal-title":"N Engl J Med"},{"issue":"6","key":"1066_CR13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.4161\/epi.24823","volume":"8","author":"L Sulaiman","year":"2013","unstructured":"Sulaiman L, et al. Global and gene-specific promoter methylation analysis in primary hyperparathyroidism. Epigenetics. 2013;8(6):646\u201355.","journal-title":"Epigenetics"},{"issue":"6","key":"1066_CR14","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1210\/jc.2017-02506","volume":"103","author":"SM Sadowski","year":"2018","unstructured":"Sadowski SM, et al. Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism. J Clin Endocrinol Metab. 2018;103(6):2189\u201398.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1066_CR15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/jbmr.3674","volume":"34","author":"N Balenga","year":"2019","unstructured":"Balenga N, et al. Parathyroid-Targeted Overexpression of Regulator of G-Protein Signaling 5 (RGS5) Causes Hyperparathyroidism in Transgenic Mice. J Bone Miner Res. 2019;34(5):955\u201363.","journal-title":"J Bone Miner Res"},{"key":"1066_CR16","doi-asserted-by":"crossref","unstructured":"Rodriguez-Ortiz ME, Rodriguez M. Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease. F1000Res.\u00a02020;9.","DOI":"10.12688\/f1000research.22636.1"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01066-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-01066-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01066-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T20:49:16Z","timestamp":1654807756000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-01066-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1066"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-01066-8","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"17 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by China Japan Friendship Hospital ethics committee.All methods were carried out in accordance with declaration of Helsinki.Informed consent\u00a0was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}